Clinitech Laboratory IPO to open for subscription tomorrow; check price band, issue size, more. | Stock Market News

The IPO of Clinitech Laboratory Ltd will open for subscriptions on Thursday, July 25, and will close on Monday, July 29. Each share has a face value of ₹10, and the price is set at ₹96 per share. Investors can bid for a minimum of 1,200 shares or multiples thereof.

Clinitech Laboratory operates eight diagnostic clinics in Thane and Navi Mumbai, offering a wide range of tests and healthcare services. The company’s promoters have over 30 years of experience in the diagnostic industry. Clinitech’s labs, accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL), conduct more than three lakh tests annually with advanced technology and equipment.

The company offers over 150 different tests in areas such as immunology, hematology, molecular biology, serology, microbiology, histopathology, and biochemistry.

According to the prospectus, Clinitech’s peers include Dr. Lalpath Labs (P/E of 67.92), Thyrocare (P/E of 47.56), and Krsnaa Diagnostics (P/E of 38.42).

Clinitech’s profit after tax (PAT) decreased by 39.46% while its sales increased by 1.19% in the fiscal years ending on March 31, 2024, and March 31, 2023.

Clinitech Laboratory IPO Details:

• IPO Value: ₹5.78 crore
• Fresh Issuance: 602,400 equity shares with a face value of ₹10
• Offer for Sale: None
• Use of Proceeds: General corporate purposes and expansion of diagnostic centers

Managers:

• Book Running Lead Manager: Inventure Merchant Banker Services Pvt Ltd
• Registrar: Bigshare Services Pvt Ltd
• IPO Market Maker: Svcm Securities